PharmaVoice

Pharma Tech

J&J raises FY26 outlook following positive Q2

Contributing around $8.9bn to its Q2 revenues of around $25.3bn, J&J MedTech’s performance was driven by its cardiovascular portfolio that includes the Shockwave IVL system.

Read Full Article

Pharma Tech

Women’s health attracted record equity in 2025 as companies share capital

Closing the gender gap could boost the global economy by at least $1tn annually by 2040.

Read Full Article

Pharma Tech

AAIC26: The role of biomarkers in primary care and early diagnostics

Blood-based biomarkers could play a key role in detecting and treating Alzheimer’s early at the first point of contact, experts say.

Read Full Article

Pharma Tech

FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN

The FDA has granted priority review to Roche’s sBLA for Gazyva/Gazyvaro in the treatment of adults with pMN.

Read Full Article

Express Pharma

Bayer appoints Simon Rosof as Head of Asia Pacific Pharmaceuticals

Rosof assumes regional leadership role and will also oversee the ASEAN cluster from Singapore The post Bayer appoints Simon Rosof as Head of Asia Pacific Pharmaceuticals appeared first on Express Pharma.

Read Full Article

Featured promotional

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Jul 15, 2026, 2:14 PM

J&J raises FY26 outlook following positive Q2

Contributing around $8.9bn to its Q2 revenues of around $25.3bn, J&J MedTech’s performance was driven by its cardiovascular portfolio that includes the Shockwave IVL system.

J&J raises FY26 outlook following positive Q2

Women’s health attracted record equity in 2025 as companies share capital

AAIC26: The role of biomarkers in primary care and early diagnostics

FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN

Bayer appoints Simon Rosof as Head of Asia Pacific Pharmaceuticals

Featured promotional

Jeplus.in

Latest stories

J&J raises FY26 outlook following positive Q2

Women’s health attracted record equity in 2025 as companies share capital

Merck Reports P-III (KEYNOTE C93) Trial Data on Keytruda for Endometrial Cancer with dMMR Tumors

AAIC26: The role of biomarkers in primary care and early diagnostics

Taiwan&#039;s Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine

Chai Discovery Raises $400M Series C to Advance AI-Driven Drug Discovery

Latest industry coverage

Testimony to the Special Committee on Aging Regarding Foreign Ownership and Control in America’s Drug Supply Chain - Information Technology and Innovation Foundation (ITIF)

Dual Chamber Prefilled Syringes Market Size, Industry Analysis, Demand & Forecast 2035 - Global Growth Insights

Brazil retailer Assai to launch pharmacy operation with Sao Paulo store - Reuters

AAPS Reveals Opening and Closing Plenary Speakers for PharmSci 360 - Contract Pharma

Eli Lilly is reinventing the pharma business - The Economist

America must win the biotech competition with China - Washington Times

Why VERAXA Biotech (VRXA) Could Benefit More Than Others From AI's Growing Impact on Drug R&D - NewMediaWire

Philadelphia nonprofit Rx-360 taps former FDA official as CEO - The Business Journals

Johnson & Johnson CFO Says Guidance Hike Is Just the Start - Barron's

Featured promotions

Jeplus.in

Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine